Full name
DOBRY LEK SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
2019 | 2020 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 0,9 | 82,3 |
Gross profit (loss) | 0,6 | 1 | 74,3 |
EBITDA | 0,6 | 1 | 70,9 |
Short time liabilities | 0,9 | 1,5 | 67,2 |
Other operating costs | 0 | 0 | -9,2 |
Equity capital | 0,8 | 1,2 | 55 |
Operating profit (EBIT) | 0,6 | 1 | 70,9 |
Assets | 1,8 | 3,1 | 74,7 |
Net profit (loss) | 0,6 | 1 | 74,3 |
Cash | 0,3 | 0,1 | -43,5 |
Net income from sale | 9,6 | 10,5 | 9,6 |
Liabilities and provisions for liabilities | 1 | 1,9 | 90 |
Working assets | 1,6 | 2,9 | 84,7 |
Other income costs | 0,1 | 0,1 | 10,9 |
Depreciation | 0 | 0 | 72,4 |
% | % | p.p. | |
Profitability of capital | 74,1 | 83,3 | 9,2 |
Equity capital to total assets | 43,6 | 38,7 | -4,9 |
Gross profit margin | 6 | 9,5 | 3,5 |
EBITDA Margin | 6,4 | 9,9 | 3,5 |
Days | Days | Days | |
Short term commitment turnover cycle | 34 | 52 | 18 |
Current financial liquidity indicator | 1.74647855758667 | 1.9289907217025757 | 0,2 |
Net dept to EBITDA | -0.26965269446372986 | 0.8752548694610596 | 1,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane